deltatrials
Completed PHASE4 NCT00437008

Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes

Acute Effects of a Low-AGE vs. High-AGE Meal on Postprandial Endothelial Function in People With Type 2 Diabetes Mellitus. Protective Effects of Benfotiamine

Sponsor: Ruhr University of Bochum

Conditions Endothelial Dysfunction Type 2 Diabetes Mellitus
Interventions Benfotiamine 1050mg, 3 days high-AGE vs. low-AGE meal
Updated 4 times since 2017 Last updated: Feb 15, 2007 Started: Nov 30, 2004 Completion: Jan 31, 2006

A PHASE4 clinical study on Endothelial Dysfunction and Type 2 Diabetes Mellitus, this trial is completed. The trial is conducted by Ruhr University of Bochum and has accumulated 4 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ruhr University of Bochum
Data source: Ruhr University of Bochum

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bad Oeynhausen, Germany